These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases. Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579 [TBL] [Abstract][Full Text] [Related]
3. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment. Ebo D; DeClerck LS; Bridts CH; Stevens WJ In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494 [TBL] [Abstract][Full Text] [Related]
4. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137 [TBL] [Abstract][Full Text] [Related]
5. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations. Moutsopoulos HM; Fauci AS J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308 [TBL] [Abstract][Full Text] [Related]
6. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases. Ramos-Casals M; Jara LJ; Medina F; Rosas J; Calvo-Alen J; Mañá J; Anaya JM; Font J; J Intern Med; 2005 Jun; 257(6):549-57. PubMed ID: 15910559 [TBL] [Abstract][Full Text] [Related]
7. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease. Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526 [TBL] [Abstract][Full Text] [Related]
8. The immunology of rheumatoid diseases. Koffler D Clin Symp; 1979; 31(4):1-36. PubMed ID: 45382 [No Abstract] [Full Text] [Related]
9. [Association of systemic lupus erythematosus and Sjögren's syndrome]. Szántó A; Kiss E; Sas A; Szegedi G; Zeher M Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498 [TBL] [Abstract][Full Text] [Related]
10. [Antibody-dependent and natural cellular cytotoxic reactions in rheumatic diseases]. Aleksandrova EN; Zimin IuI; Nasonov EL Ter Arkh; 1984; 56(10):130-6. PubMed ID: 6084315 [No Abstract] [Full Text] [Related]
11. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry). Ramos-Casals M; Muñoz S; Medina F; Jara LJ; Rosas J; Calvo-Alen J; Brito-Zerón P; Forns X; Sánchez-Tapias JM; J Rheumatol; 2009 Jul; 36(7):1442-8. PubMed ID: 19369460 [TBL] [Abstract][Full Text] [Related]
12. Post-mortem prevalence of lymphocytic infiltration of the lacrymal gland: a comparative study in autoimmune and non-autoimmune diseases. Nasu M; Matsubara O; Yamamoto H J Pathol; 1984 May; 143(1):11-5. PubMed ID: 6737113 [TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent direct cytotoxicity of human lymphocytes. I. Studies on peripheral blood lymphocytes and sera of patients with systemic lupus erythematosus. Scheinberg MA; Cathcart ES Clin Exp Immunol; 1976 May; 24(2):317-22. PubMed ID: 1084243 [TBL] [Abstract][Full Text] [Related]
14. IgG subclasses of anti-tetanus toxoid antibodies in adult and newborn normal subjects and in patients with systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity. Rubin RL; Tang FL; Lucas AH; Spiegelberg HL; Tan EM J Immunol; 1986 Oct; 137(8):2522-7. PubMed ID: 3760565 [TBL] [Abstract][Full Text] [Related]
15. High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome. Moutsopoulos HM; Steinberg AD; Fauci AS; Lane HC; Papadopoulos NM J Immunol; 1983 Jun; 130(6):2663-5. PubMed ID: 6406594 [TBL] [Abstract][Full Text] [Related]
16. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism. Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194 [TBL] [Abstract][Full Text] [Related]
17. Antibody-dependent cell-mediated cytotoxicity by peripheral blood mononuclear cells from patients with Sjögren's syndrome, with special reference to differentiation from phagocytic activity. Ichikawa Y; Takaya M; Arimori S Tokai J Exp Clin Med; 1980 Jan; 5(1):83-90. PubMed ID: 7385266 [TBL] [Abstract][Full Text] [Related]
18. Selective decrease in antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus and progressive systemic sclerosis. Cooper SM; Harding B; Mirick GR; Schneider J; Quismorio FP; Friou GJ Clin Exp Immunol; 1978 Nov; 34(2):235-40. PubMed ID: 737908 [TBL] [Abstract][Full Text] [Related]
19. Lymphopenia in Sjögren's syndrome with rheumatoid arthritis: relationship to lymphocytotoxic antibodies, cryoglobulinemia, and impaired mitogen responsiveness. Utsinger PD; Yount WJ J Rheumatol; 1976 Dec; 3(4):355-66. PubMed ID: 1088165 [TBL] [Abstract][Full Text] [Related]